JBHT
56
-3
AN
50
-5
ALL
50
2
WYNN
36
-5
CMA
61
-3
TSN
50
-2
LEN
50
-2
HBI
58
3
FMC
23
-3
URBN
48
-6
AIZ
82
2
CSCO
58
-2
CAG
24
-3
PGR
59
-3
C
62
4
CCI
30
-11
TEL
60
-8
WM
74
-5
MCHP
34
-2
EFX
30
-8
JBHT
56
-3
AN
50
-5
ALL
50
2
WYNN
36
-5
CMA
61
-3
TSN
50
-2
LEN
50
-2
HBI
58
3
FMC
23
-3
URBN
48
-6
AIZ
82
2
CSCO
58
-2
CAG
24
-3
PGR
59
-3
C
62
4
CCI
30
-11
TEL
60
-8
WM
74
-5
MCHP
34
-2
EFX
30
-8
Financhill
Back

FlexShares Disciplined Duration MBS ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

MBSD
FlexShares Disciplined Duration MBS ETF

Last Price:
20.40
Seasonality Move:
-0.13%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
FlexShares Disciplined Duration MBS ETF (MBSD) is a Sell

Is FlexShares Disciplined Duration MBS ETF a Buy, Sell or Hold?

  • The current FlexShares Disciplined Duration MBS ETF [MBSD] share price is $20.39. The Score for MBSD is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • MBSD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MBSD Stock Price Chart

What is FlexShares Disciplined Duration MBS ETF's stock price today?

  • The FlexShares Disciplined Duration MBS ETF share price today is $20.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBSD is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MBSD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.22 Sell
Chaikin Money Flow: 4303 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.41 - 20.65) Sell
Bollinger Bands (100): (20.45 - 20.95) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MBSD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.43 Sell
20-day SMA: 20.48 Sell
50-day SMA: 20.75 Sell
200-day SMA: 20.47 Sell
8-day EMA: 20.43 Sell
20-day EMA: 20.5 Sell
50-day EMA: 20.63 Sell
200-day EMA: 20.53 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

FlexShares Disciplined Duration MBS ETF Earnings Growth & MBSD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

FlexShares Disciplined Duration MBS ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):